General Information of Drug Inactive Ingredient (DIG) (ID: E00498)

DIG Name
Sodium phosphate dibasic dihydrate
Synonyms
10028-24-7; Disodium phosphate dihydrate; Sodium Hydrogenphosphate Dihydrate; Disodium hydrogen phosphate dihydrate; Sodium phosphate dibasic dihydrate; Phosphoric acid, disodium salt, dihydrate; di-Sodium hydrogen phosphate dihydrate; MFCD00149182; UNII-94255I6E2T; Sodium phosphate, dibasic, dihydrate; dibasic dihydratesodium phosphate; disodium;hydrogen phosphate;dihydrate; 94255I6E2T; DISODIUM HYDROGENPHOSPHATE DIHYDRATE; Sodium phosphate dibasic dihydrate, 99+%, for HPLC; Sodium phosphate dibasic dihydrate, 98+%, for analysis; 2Na.HPO4.2H2O; Disodium phosphate 2-hydrate; CHEMBL2107560; Disodium orthophosphate dihydrate; DTXSID1074250; CHEBI:91258; sodium hydrogen phosphate dihydrate; 5248AF; sodium monohydrogen phosphate dihydrat; AKOS015913903; AKOS028109191; sodium hydrogen orthophosphate dihydrate; sodium hydrogen phosphate--water (1/2); FT-0625317; Sodium phosphate dibasic dihydrate, LR, >=98%; Sodium phosphate dibasic dihydrate, p.a., 99.0%; Phosphoric acid, disodium salt, dihydrate (8CI,9CI); Q27163166; UNII-GR686LBA74 component KDQPSPMLNJTZAL-UHFFFAOYSA-L; UNII-SE337SVY37 component KDQPSPMLNJTZAL-UHFFFAOYSA-L; Sodium phosphate dibasic dihydrate, BioUltra, >=99.0% (T); Sodium phosphate dibasic dihydrate, purum p.a., >=98.0% (T); Sodium phosphate dibasic dihydrate, tested according to Ph.Eur.; Sodium phosphate dibasic dihydrate, Vetec(TM) reagent grade, 98%; Sodium phosphate dibasic dihydrate, BioUltra, for molecular biology, >=99.0% (T); Sodium phosphate dibasic dihydrate, puriss. p.a., buffer substance, >=99.5%; Sodium phosphate dibasic dihydrate, meets analytical specification of Ph.??Eur., BP, 98.5-101% (calc. to the dried substance); Sodium phosphate dibasic dihydrate, PharmaGrade, USP, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.; Sodium phosphate dibasic dihydrate, puriss. p.a., Reag. Ph. Eur., 98.5-101.0% (calc. to the dried substance)
DIG Function
Buffering agent; Complexing agent
Formula
H5Na2O6P
Canonical SMILES
O.O.OP(=O)([O-])[O-].[Na+].[Na+]
InChI
1S/2Na.H3O4P.2H2O/c;;1-5(2,3)4;;/h;;(H3,1,2,3,4);2*1H2/q2*+1;;;/p-2
InChIKey
KDQPSPMLNJTZAL-UHFFFAOYSA-L
Physicochemical Properties Molecular Weight 177.99 Topological Polar Surface Area 85.4
XlogP N.A. Complexity 46.5
Heavy Atom Count 9 Rotatable Bond Count 0
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 6

Full List of Drug(s) Co-administrated with This DIG

6 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Fluorometholone DM2HKC4 Chronic obstructive pulmonary disease [CA22] Fluorometholone 0.1% suspension F23171
Omeprazole DM471KJ Cystic fibrosis [CA25] Omeprazole 10 mg capsule F15815
Oxacillin DMTAFY4 Bacterial infection [1A00-1C4Z] Oxacillin 1g/20ml powder F23853
Polidocanol DMH1KMT Reticular veins [EF20] Polidocanol 180mg/18ml solution F24222
Ranitidine DM0GUSX Gastric ulcer [DA60] Ranitidine Hydrochloride eq 25 mg base/mL injectable F23535
Regadenoson DM76VHG Radionuclide imaging [N.A.] Regadenoson 0.4mg/5ml solution F23266
------------------
⏷ Show the Full List of 6 Approved Drug(s)